The role of glutathione in cancer - PubMed (original) (raw)
Review
. 2004 Nov-Dec;22(6):343-52.
doi: 10.1002/cbf.1149.
Affiliations
- PMID: 15386533
- DOI: 10.1002/cbf.1149
Review
The role of glutathione in cancer
Ganesaratnam K Balendiran et al. Cell Biochem Funct. 2004 Nov-Dec.
Abstract
Glutathione is an abundant natural tripeptide found within almost all cells. Glutathione is highly reactive and is often found conjugated to other molecules via its sulfhydryl moiety. It instils several vital roles within a cell including antioxidation, maintenance of the redox state, modulation of the immune response and detoxification of xenobiotics. With respect to cancer, glutathione metabolism is able to play both protective and pathogenic roles. It is crucial in the removal and detoxification of carcinogens, and alterations in this pathway, can have a profound effect on cell survival. However, by conferring resistance to a number of chemotherapeutic drugs, elevated levels of glutathione in tumour cells are able to protect such cells in bone marrow, breast, colon, larynx and lung cancers. Here we present a number of studies investigating the role of glutathione in promoting cancer, impeding chemotherapy, and the use of glutathione modulation to enhance anti-neoplastic therapy.
Copyright (c) 2004 John Wiley & Sons, Ltd.
Similar articles
- Modulation of xenobiotic metabolising enzymes by anticarcinogens -- focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis.
Pool-Zobel B, Veeriah S, Böhmer FD. Pool-Zobel B, et al. Mutat Res. 2005 Dec 11;591(1-2):74-92. doi: 10.1016/j.mrfmmm.2005.04.020. Epub 2005 Aug 3. Mutat Res. 2005. PMID: 16083918 Review. - Role of glutathione in cancer pathophysiology and therapeutic interventions.
Singh S, Khan AR, Gupta AK. Singh S, et al. J Exp Ther Oncol. 2012;9(4):303-16. J Exp Ther Oncol. 2012. PMID: 22545423 Review. - Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review.
Yang P, Ebbert JO, Sun Z, Weinshilboum RM. Yang P, et al. J Clin Oncol. 2006 Apr 10;24(11):1761-9. doi: 10.1200/JCO.2005.02.7110. J Clin Oncol. 2006. PMID: 16603718 Review. - Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance.
Pompella A, De Tata V, Paolicchi A, Zunino F. Pompella A, et al. Biochem Pharmacol. 2006 Jan 12;71(3):231-8. doi: 10.1016/j.bcp.2005.10.005. Epub 2005 Nov 21. Biochem Pharmacol. 2006. PMID: 16303117 Review. - Glutathione and glutathione-dependent enzymes in cancer drug resistance.
McLellan LI, Wolf CR. McLellan LI, et al. Drug Resist Updat. 1999 Jun;2(3):153-164. doi: 10.1054/drup.1999.0083. Drug Resist Updat. 1999. PMID: 11504486
Cited by
- Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment.
Tu Y, Gong J, Mou J, Jiang H, Zhao H, Gao J. Tu Y, et al. Front Pharmacol. 2024 Jul 31;15:1434137. doi: 10.3389/fphar.2024.1434137. eCollection 2024. Front Pharmacol. 2024. PMID: 39144632 Free PMC article. Review. - Targeted Polymeric Micelles System, Designed to Carry a Combined Cargo of L-Asparaginase and Doxorubicin, Shows Vast Improvement in Cytotoxic Efficacy.
Zlotnikov ID, Kudryashova EV. Zlotnikov ID, et al. Polymers (Basel). 2024 Jul 26;16(15):2132. doi: 10.3390/polym16152132. Polymers (Basel). 2024. PMID: 39125158 Free PMC article. - Identification of Key Genes Associated with Polycystic Ovarian Syndrome and Endometrial and Ovarian Cancer through Bioinformatics.
Raulo K, Qazi S. Raulo K, et al. J Hum Reprod Sci. 2024 Apr-Jun;17(2):81-93. doi: 10.4103/jhrs.jhrs_44_24. Epub 2024 Jun 28. J Hum Reprod Sci. 2024. PMID: 39091436 Free PMC article. - Biosensors for Cancer Biomarkers Based on Mesoporous Silica Nanoparticles.
Mladenović M, Jarić S, Mundžić M, Pavlović A, Bobrinetskiy I, Knežević NŽ. Mladenović M, et al. Biosensors (Basel). 2024 Jun 30;14(7):326. doi: 10.3390/bios14070326. Biosensors (Basel). 2024. PMID: 39056602 Free PMC article. Review. - Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy.
Roy N, Paira P. Roy N, et al. ACS Omega. 2024 Apr 16;9(19):20670-20701. doi: 10.1021/acsomega.3c08890. eCollection 2024 May 14. ACS Omega. 2024. PMID: 38764686 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources